taspine has been researched along with quinazolines in 1 studies
| Studies (taspine) | Trials (taspine) | Recent Studies (post-2010) (taspine) | Studies (quinazolines) | Trials (quinazolines) | Recent Studies (post-2010) (quinazolines) |
|---|---|---|---|---|---|
| 51 | 0 | 26 | 19,235 | 2,417 | 8,835 |
| Protein | Taxonomy | taspine (IC50) | quinazolines (IC50) |
|---|---|---|---|
| Epidermal growth factor receptor | Homo sapiens (human) | 0.027 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fan, M; Kang, Y; Shi, X; Yang, T; Zhang, D; Zhang, Y; Zhu, M | 1 |
1 other study(ies) available for taspine and quinazolines
| Article | Year |
|---|---|
Novel compounds TAD-1822-7-F2 and F5 inhibited HeLa cells growth through the JAK/Stat signaling pathway.
Topics: Alkaloids; Cell Nucleus; Cell Proliferation; HeLa Cells; Humans; Janus Kinases; Models, Biological; Phosphorylation; Quinazolines; Signal Transduction; STAT Transcription Factors; Subcellular Fractions | 2018 |